The rockefeller university

A high-throughput screen is not simply a larger version of a bench experiment.
Before thousands of compounds are tested, the assay, automation, controls, data analysis,
and follow-up strategy need to work together as a complete screening system.

The purpose of screening is not to test as many compounds as possible. It is to generate
reliable data from which promising activity can be identified, reproduced, and investigated.
Preparing for a screen therefore begins well before the first compound plate is opened.

Make Sure the Assay Is Ready to Scale

An assay that performs well in a small experiment may behave differently when transferred
to microplates and automated liquid handling. Smaller volumes can magnify the effects of
dispensing error, evaporation, mixing, timing, plate position, and reagent stability.

Before screening, the assay should be tested in the plate format, volume, and workflow
that will actually be used. Positive and negative controls should produce a reproducible
assay window across the plate and from plate to plate.

The objective is not merely to demonstrate that the assay works. It is to demonstrate
that it works repeatedly under screening conditions.

Design the Plate Before You Design the Screen

Plate layout is part of experimental design.

Controls should be distributed so that assay performance can be evaluated on every plate.
Their placement can also help identify positional effects caused by evaporation, temperature,
dispensing, or other systematic sources of variation.

The choice of plate format and material can matter as well. Well geometry, surface
properties, optical characteristics, and compatibility with the detection method can all
affect assay performance.

A good plate design provides enough controls to recognize when something has gone wrong
without consuming unnecessary assay capacity.

Test the Actual Automated Workflow

Automation introduces variables that may not be apparent when an assay is performed manually.
Dispensing speed and accuracy, mixing, order of addition, incubation intervals, plate handling,
and the time required to process multiple plates can all affect the result.

For this reason, assay performance should ultimately be evaluated using the same instruments
and sequence of operations planned for the screen.

Timing deserves particular attention. A protocol that is easy to execute on one plate may
produce substantial differences between the first and last plates of a larger batch if the
biological response continues to change during processing.

Know How You Will Evaluate Assay Performance

Screening quality should be assessed throughout the campaign, not only during assay development.
Positive and negative controls provide the reference points for evaluating individual plates
and normalizing experimental measurements.

Metrics such as signal-to-background, coefficient of variation (CV), and Z′ can help identify
changes in assay performance. Plate patterns and systematic shifts in control values can reveal
problems that a single summary statistic may miss.

A plate that fails predetermined quality criteria should be investigated rather than simply
included because the compounds have already been tested.

Run a Pilot Screen

One of the best tests of screening readiness is a small pilot performed under conditions that
closely reproduce the intended campaign.

A pilot screen tests more than the assay. It tests the entire process: compound transfer,
liquid handling, incubation, detection, controls, data processing, normalization, quality
assessment, and hit identification.

It can also reveal effects caused by real screening compounds that are absent when assay
performance is evaluated using controls alone.

The goal of the pilot is to discover problems while they are still inexpensive to fix.

Decide What a Hit Means Before You Find One

A hit threshold should reflect the assay, its variability, and the objectives of the campaign.
Depending on the experiment, activity may be defined relative to plate controls, statistical
properties of the screened population, a predetermined biological threshold, or a combination
of these approaches.

The number of hits also matters operationally. A threshold that identifies thousands of
compounds is useful only if there is a strategy and sufficient capacity to evaluate them.
Conversely, an excessively restrictive threshold may discard weaker but potentially meaningful
activity.

Hit selection is therefore both a statistical and a scientific decision.

Plan the Screening Cascade in Advance

The primary screen is only the first stage of compound evaluation.

Before screening begins, consider what will happen to an active compound next. A typical
follow-up strategy may include repeat testing, concentration-response measurements,
counter-screens, orthogonal assays, selectivity studies, and experiments designed to identify
assay interference or nonspecific activity.

Planning these experiments in advance helps ensure that the primary assay generates hits that
can actually be investigated.

Preserve the Data Behind the Hits

The compounds selected as hits are not the only valuable result of a screen.

Control measurements, plate-level quality metrics, raw and normalized values, compound
identifiers, concentrations, plate positions, and experimental metadata provide the context
needed to interpret results, investigate anomalies, compare experiments, and revisit the data
later.

Screening generates a dataset, not simply a list of active compounds. Preserving that dataset
makes subsequent analysis more powerful and conclusions more defensible.

Screening Is the Beginning of an Experimental Cycle

A well-designed screen produces hypotheses for the next experiment.

Hits are confirmed, characterized, challenged with alternative assays, and compared with
related compounds. Those results may lead back to the original assay, suggest new experiments,
or change which chemical series or biological mechanisms are pursued.

High-throughput screening is therefore not a single event. It is part of an iterative process
of experimentation, analysis, and refinement.

When Should You Talk to the DDRC?

Ideally, before the assay is considered screening-ready.

The DDRC can help evaluate assay robustness, miniaturization, controls, plate design,
automation, pilot studies, screening strategy, data analysis, and the experiments needed to
follow up primary activity.

Early planning can also help determine whether high-throughput screening is the appropriate
next experiment—or whether additional assay development or a smaller pilot study would provide
more useful information first.

The goal is not simply to complete a screen. It is to generate results worth
following.